Improvement of hallucinogen persisting perception disorder by treatment with a combination of fluoxetine and olanzapine: case report.
Aldurra
G
G
Crayton
J W
JW
D000293:Adolescent; D001569:Benzodiazepines; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use*; D006213:Hallucinogens / Q000009:adverse effects; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D008297:Male; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011605:Psychoses, Substance-Induced / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D001569:Benzodiazepines; D005473:Fluoxetine; D006213:Hallucinogens; D008238:Lysergic Acid Diethylamide; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors